Literature DB >> 22843262

Trajectory of white matter hyperintensity burden preceding mild cognitive impairment.

Lisa C Silbert1, Hiroko H Dodge, Louie G Perkins, Lena Sherbakov, David Lahna, Deniz Erten-Lyons, Randall Woltjer, Lynne Shinto, Jeffrey A Kaye.   

Abstract

OBJECTIVE: To determine the time of acceleration in white matter hyperintensity (WMH) burden, a common indicator of cerebrovascular pathology, in relation to conversion to mild cognitive impairment (MCI) in the elderly.
METHODS: A total of 181 cognitively intact elderly volunteers from the longitudinal, prospective, Oregon Brain Aging Study underwent yearly evaluations, including brain MRI, and cognitive testing. MRIs were analyzed for imaging markers of neurodegeneration: WMH and ventricular CSF (vCSF) volumes. The time before MCI, when the changes in WMH and vCSF burden accelerate, was assessed using a mixed-effects model with a change point for subjects who developed MCI during follow-up.
RESULTS: During a follow-up duration of up to 19.6 years, 134 subjects converted to MCI. Acceleration in %WMH volume increase occurred 10.6 years before MCI onset. On average, the annual rate of change in %WMH increased an additional 3.3% after the change point. Acceleration in %vCSF volume increase occurred 3.7 years before the onset of MCI. Out of 63 subjects who converted to MCI and had autopsy, only 28.5% had Alzheimer disease (AD) as the sole etiology of their dementia, while almost just as many (24%) had both AD and significant ischemic cerebrovascular disease present.
CONCLUSIONS: Acceleration in WMH burden, a common indicator of cerebrovascular disease in the elderly, is a pathologic change that emerges early in the presymptomatic phase leading to MCI. Longitudinal changes in WMH may thus be useful in determining those at risk for cognitive impairment and for planning strategies for introducing disease-modifying therapies prior to dementia onset.

Entities:  

Mesh:

Year:  2012        PMID: 22843262      PMCID: PMC3421153          DOI: 10.1212/WNL.0b013e3182661f2b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants.

Authors:  Lon White; Helen Petrovitch; John Hardman; James Nelson; Daron G Davis; G Webster Ross; Kamal Masaki; Lenore Launer; William R Markesbery
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

2.  Brain volume preserved in healthy elderly through the eleventh decade.

Authors:  E A Mueller; M M Moore; D C Kerr; G Sexton; R M Camicioli; D B Howieson; J F Quinn; J A Kaye
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

Review 3.  Pathophysiology of age-related cerebral white matter changes.

Authors:  Leonardo Pantoni
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

4.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

5.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

Authors:  F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

6.  Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.

Authors:  W T Longstreth; Alice M Arnold; Norman J Beauchamp; Teri A Manolio; David Lefkowitz; Charles Jungreis; Calvin H Hirsch; Daniel H O'Leary; Curt D Furberg
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

7.  Predicting the rate of cognitive decline in aging and early Alzheimer disease.

Authors:  S Adak; K Illouz; W Gorman; R Tandon; E A Zimmerman; R Guariglia; M M Moore; J A Kaye
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

8.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults.

Authors:  C DeCarli; D G Murphy; M Tranh; C L Grady; J V Haxby; J A Gillette; J A Salerno; A Gonzales-Aviles; B Horwitz; S I Rapoport
Journal:  Neurology       Date:  1995-11       Impact factor: 9.910

9.  Regional pattern of white matter microstructural changes in normal aging, MCI, and AD.

Authors:  D Y Lee; E Fletcher; O Martinez; M Ortega; N Zozulya; J Kim; J Tran; M Buonocore; O Carmichael; C DeCarli
Journal:  Neurology       Date:  2009-10-21       Impact factor: 9.910

10.  Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers.

Authors:  R Schmidt; F Fazekas; H Offenbacher; T Dusek; E Zach; B Reinhart; P Grieshofer; W Freidl; B Eber; M Schumacher
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

View more
  50 in total

1.  Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

Authors:  Adam M Brickman; Laura B Zahodne; Vanessa A Guzman; Atul Narkhede; Irene B Meier; Erica Y Griffith; Frank A Provenzano; Nicole Schupf; Jennifer J Manly; Yaakov Stern; José A Luchsinger; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2014-07-21       Impact factor: 4.673

2.  Loss of fornix white matter volume as a predictor of cognitive impairment in cognitively normal elderly individuals.

Authors:  Evan Fletcher; Mekala Raman; Philip Huebner; Amy Liu; Dan Mungas; Owen Carmichael; Charles DeCarli
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

3.  When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.

Authors:  Justin E Karr; Raquel B Graham; Scott M Hofer; Graciela Muniz-Terrera
Journal:  Psychol Aging       Date:  2018-03

4.  Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease.

Authors:  Hiroko H Dodge; Jian Zhu; Danielle Harvey; Naomi Saito; Lisa C Silbert; Jeffrey A Kaye; Robert A Koeppe; Roger L Albin
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

Review 5.  At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Authors:  Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

6.  Role of soluble epoxide hydrolase in age-related vascular cognitive decline.

Authors:  Jonathan W Nelson; Jennifer M Young; Rohan N Borkar; Randy L Woltjer; Joseph F Quinn; Lisa C Silbert; Marjorie R Grafe; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-09-30       Impact factor: 3.072

7.  Pathologies Underlying Longitudinal Cognitive Decline in the Oldest Old.

Authors:  Madeline T Nguyen; Nora Mattek; Randy Woltjer; Diane Howieson; Lisa Silbert; Scott Hofer; Jeffrey Kaye; Hiroko Dodge; Deniz Erten-Lyons
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

8.  Alzheimer disease prevention: New optimism.

Authors:  Christopher M Filley
Journal:  Neurol Clin Pract       Date:  2015-06

9.  Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals.

Authors:  Eseosa T Ighodaro; Erin L Abner; David W Fardo; Ai-Ling Lin; Yuriko Katsumata; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Janna H Neltner; Sarah E Monsell; Walter A Kukull; Debra K Moser; Frank Appiah; Adam D Bachstetter; Linda J Van Eldik; Peter T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-06       Impact factor: 6.200

Review 10.  Nutrition in Cardioskeletal Health.

Authors:  Kathleen M Hill Gallant; Connie M Weaver; Dwight A Towler; Sowmyanarayanan V Thuppal; Regan L Bailey
Journal:  Adv Nutr       Date:  2016-05-16       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.